Zimbabwe has declined a significant US healthcare agreement valued at $367m (£272m) spanning five years over Washington's request for confidential biological samples.
This rejection came to light after a official document from December was disclosed, revealing that Head of State Emmerson Mnangagwa believed the agreement was "unbalanced".
A government spokesman later clarified that the United States was demanding access to biological samples for scientific study and commercial gain but refused to guarantee the benefits from any future medical innovations.
"We must now begin the difficult and regrettable process of winding down our health assistance in Zimbabwe," said US ambassador to Zimbabwe Pamela Tremont publicly.
Her embassy noted the United States had donated over $1.9bn in health funding to Zimbabwe over the last twenty years.
A doctors' association in Zimbabwe has appealed for more talks to find a agreement suitable to both sides so the nation's critical HIV treatment initiative can proceed.
Broader Implications
Zimbabwe's decision comes after a similar situation in neighbouring Kenya, where a court halted a related health funding agreement following concerns were raised about the safety of citizens' health data.
After returning to the presidency last year, US President Donald Trump has reduced foreign aid and closed the key foreign aid agency.
The agency had overseen assistance for the US government, but Trump argued its spending was "wasteful" and his administration was pursuing direct bilateral deals to enhance openness and accountability.
Based on reports, Sixteen nations in Africa have so far signed these new health pacts, representing more than $18.3bn in committed funds.
Details of the Rejected Deal
The money for Zimbabwe would have funded "combating HIV/Aids, tuberculosis, malaria, maternal and child health, and disease outbreak preparedness.
"We are confident this partnership would have delivered significant benefits for the people of Zimbabwe, particularly the 1.2 million men, women and children currently on HIV treatment via US-supported programmes," the Ambassador commented.
However, government spokesperson Nick Mangwana maintained the arrangement was "unequal".
"The proposal required Zimbabwe to surrender its biological resources and data indefinitely, without any corresponding promise of benefiting from any scientific breakthroughs – like vaccines, diagnostics, or treatments – that could be developed from that shared data," his statement read.
"Put simply, our nation would provide the basic resources for scientific discovery without any assurance that the resulting innovations would be available to our population if a new pandemic emerge."
National Interest and Global Health
He also noted that the US's withdrawal from the World Health Organization (WHO) and its push of one-on-one health agreements were undermining systems already set up via the global organization.
The spokesperson gave as an example its Pathogen Access and Benefit Sharing system designed to manage future global health emergencies.
"This framework is intended to guarantee that when a nation contributes its information, the resulting advantages – including vaccines and treatments – are distributed fairly, not monopolised exclusively by those with the capability to develop them."
These objections over the US deal "are not meant as opposition to America," Mangwana stressed.
"We welcome ongoing discussions with our American counterparts on how subsequent co-operation could be arranged in a way that honours the independence and dignity of both nations."
Health Experts Response
A leading public health body said it understood the government's concerns, but suggested that talks should continue given that a large portion of the nation's Aids initiatives depended on international support.
"If technical issues arise, including those relating to information security or agreement terms, these can often be resolved via detailed discussion and negotiated safeguards," it said.
The halted deal emphasises the continuing tensions between accepting much-needed international aid and safeguarding national sovereignty in an ever more interconnected world.